StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

Bullboard Posts

Comment by johnny007on Feb 04, 2018 7:06pm

159 Views

Post# 27500457

RE:Rory Riggs Total Ownership Fixed: C$0.55 - C$0.62 Average

Now that is impressive. TBH I was too lazy to calculate his average weeks ago.
Stock price moved back up after his last transaction,
but we couldn't tell whether this was due to the financing/deal or his conversion.

He is truly with the company, only early 2017 he reduced his stake a little,
but topped it back up even higher now.

Considering this, we probably should not worry too much about the execution,
especially since he converted most of his notes to common shares,
i.e. sharing all our risks.

Great job.

Bullboard Posts

Who, why, and what of the great "Crypto Surge"